Jun Zhang, MD

Assistant Professor of Clinical Medicine in Oncology, Academic Institute
Assistant Clinical Member, Research Institute
Cancer Center
Department of Medicine
Houston Methodist Hospital
Houston Methodist
Weill Cornell Medical College

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Area Keywords

Cancer

7 Not started
27 Active

Phase 1b_VenetoclaxPembrolizumab_NSCLC_Abbvie STUDY M19-700
Bernicker, E. H., Darcourt, J., Heyne, K. & Zhang, J.
12/1/20 → …
Project: Clinical Trial
Phase III_MRx0518Pembrolizumab_Solid Tumors_4D Pharma MRx0518-I-002
Bernicker, E. H., Darcourt, J. & Zhang, J.
9/25/20 → …
Project: Clinical Trial
Study of Sasanlimab (PF-06801591) in Combination With Bacillus Calmette-Guerin (BCG) in Participants With High-Risk Non-Muscle Invasive Bladder Cancer (CREST)
Satkunasivam, R., Darcourt, J., Singh, M. & Zhang, J.
8/6/20 → …
Project: Clinical Trial
An Open-label, Randomized, Controlled Phase 3 Study of Enfortumab Vedotin in Combination With Pembrolizumab With or Without Chemotherapy, Versus Chemotherapy Alone in Previously Untreated Locally Advanced or Metastatic Urothelial Cancer
Darcourt, J., Singh, M. & Zhang, J.
7/2/20 → …
Project: Clinical Trial
Phase 3 Multicenter, Double-Blind, randomized, placebo-controlled trail of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF 302)
Satkunasivam, R., Darcourt, J., Singh, M. & Zhang, J.
6/26/20 → …
Project: Clinical Trial

If you made any changes in Pure these will be visible here soon.